Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

被引：0
|
作者：
Groudan, Kevin [1 ]
Sawalha, Khalid [2 ]
Bhat, Anusha G. [1 ]
Eltanbedawi, Ahmed [1 ]
Ambesh, Paurush [3 ]
机构：
[1] Baystate Med Ctr, Internal Med, Springfield, MA 01199 USA
[2] Univ Massachusetts, Med Sch Baystate, Internal Med, Springfield, MA USA
[3] Univ Massachusetts, Med Sch Baystate, Cardiovasc Med, Springfield, MA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 08期
关键词：
hemopericardium; sirolimus; renal transplant; immunosuppression; LYMPHEDEMA;
D O I：
10.7759/cureus.9508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Cryptosporidiosis in a renal transplant patient treated with paromomycin
    Khalil-ur-Rahman
    Al-Amoudi, Abdullah
    Badreddine, Samar
    Al-Shehri, Abdulraheem M.
    Kanaan, Hassan
    Al-Ghamdi, Saeed M. G.
    ANNALS OF SAUDI MEDICINE, 2007, 27 (05) : 373 - 374
  • [32] Association of sirolimus with pericardial effusion in renal transplant patient and discussion of potential mechanism
    Meng, Lingbin
    Deng, Bo
    Liu, Baoqiong
    Gordon, Dwayne
    BMJ CASE REPORTS, 2019, 12 (07)
  • [33] First Reported Case Of Mycobacterium Chlorophenolicum Pneumonia In A Renal Transplant Patient On Sirolimus
    Kempker, J. A.
    Sandesara, P.
    Gal, A. A.
    Berkowitz, E. A.
    Bag, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Late-Onset Development of Renal Sinus Lipomatosis in a Transplant Patient on Sirolimus
    Shankaranarayanan, Divya
    Abraham, Georgi
    Mathew, Milly
    Kurien, Abraham
    Kurien, Anila
    TRANSPLANTATION, 2013, 95 (02) : E10 - E12
  • [35] Reversible sirolimus-induced pulmonary alveolar proteinosis in a renal transplant patient
    Eugenio Hinojosa-Gonzalez, David
    Davila-Gonzalez, Daniel
    Salgado-Garza, Gustavo
    Flores-Villalba, Eduardo
    LUNG INDIA, 2020, 37 (03) : 252 - 256
  • [36] Sirolimus-Induced Drug Fever in a Renal Transplant Patient: A Case Report
    Aires, I.
    Carvalho, D.
    Remedio, F.
    Possante, M.
    Ferreira, A.
    Pinto, J. R.
    Nolasco, F.
    Santos, J. R.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (03) : 957 - 958
  • [37] Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine
    Russ, Graeme
    Jamieson, Neville
    Oberbauer, Rainer
    Arias, Manuel
    Murgia, Maria G.
    Blancho, Gilles
    Sato, Reiko
    Stoeckl, Maria
    Revicki, Dennis A.
    TRANSPLANT INTERNATIONAL, 2007, 20 (10) : 875 - 883
  • [38] Sirolimus approved with renal transplant indication
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (21) : 2177 - 2178
  • [39] Angioedema in renal transplant recipients on sirolimus
    Mahe, Emmanuel
    Morelon, Emmanuel
    Lechaton, Sophie
    Kreis, Henri
    de Prost, Yves
    Bodemer, Christine
    DERMATOLOGY, 2007, 214 (03) : 205 - 209
  • [40] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function
    Moneim, HA
    Flechner, SM
    Goel, M
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, DA
    Novick, AC
    JOURNAL OF UROLOGY, 2005, 173 (04): : 419 - 419
12345